08Aug
FDA Releases New Warning Letter on Human and Animal Hemp CBD Products
On July 22, 2019, the Food and Drug Administration (“FDA”) released its fourth warning letter for cannabidiol (“CBD”) related products since the enactment of the 2018 Federal Farm Bill in December. Though not a formal action or rule-making by the...
By:
Miller & Martin PLLC
Related
When an employer permits its employees to participate in a bonus program offered by the employer’s ...
Read More >
On December 18, 2019 New York State’s Department of Health (DOH) issued a Request for Offers (RFO) ...
Read More >
FTC adjusts the Hart-Scott-Rodino Act size thresholds, raising the minimum size for reportable acqui...
Read More >
In today’s edition of Daily Compliance News: • Beny Steinmetz indicted in Switzerland over Guinea ...
Read More >
On June 13, 2019, Eighth Circuit Judge Steven M. Colloton wrote on behalf of a three-judge panel con...
Read More >
Several years ago, a trend was emerging that consisted of third-party, private marketplaces where em...
Read More >